The antineoplastic effects of the overexpression of β-catenin in rhabdomyosarcoma and osteosarcoma has been linked to a decrease in cell proliferation and apoptotic activity by inhibiting GSK3β 66. This evidence concerns the gene GSK3B and rhabdomyosarcoma.